Applications of cell therapy in the treatment of virus-associated cancers
A diverse range of viruses have well-established roles as the primary driver of oncogenesis
in various haematological malignancies and solid tumours. Indeed, estimates suggest that …
in various haematological malignancies and solid tumours. Indeed, estimates suggest that …
EBV and post-transplant lymphoproliferative disorder: a complex relationship
NK El-Mallawany, RH Rouce - Hematology, 2024 - ashpublications.org
Post-transplant lymphoproliferative disorders (PTLD) are a heterogeneous category of
disease entities occurring in the context of iatrogenic immune suppression. Epstein-Barr …
disease entities occurring in the context of iatrogenic immune suppression. Epstein-Barr …
Celebrating a year of immunotherapy/cell and gene therapy in Blood Advances
CM Bollard, AS Weyrich - Blood Advances, 2024 - ashpublications.org
With the close of 2024, we wanted to take stock of the eighth year for Blood Advances, which
had another banner year. We continue to receive an impressive number of submissions …
had another banner year. We continue to receive an impressive number of submissions …
The IPTA Nashville consensus conference on post‐transplant lymphoproliferative disorders after solid organ transplantation in children: IV‐consensus guidelines for …
Abstract The International Pediatric Transplant Association convened an expert consensus
conference to assess current evidence and develop recommendations for various aspects of …
conference to assess current evidence and develop recommendations for various aspects of …
Virus-Specific T-Cell Therapy for the Management of Viral Infections in the Immunocompromised
Background: Immunocompromised individuals are at major risk for severe infectious
complications. This is particularly relevant in the context of allogeneic hematopoietic stem …
complications. This is particularly relevant in the context of allogeneic hematopoietic stem …